Surveillance of Bacterial Meningitis, Ethiopia, 2012-2013

Insights

Meningococci and pneumococci were the primary causes of bacterial meningitis in Ethiopia. The study highlights an urgent need for affordable, multivalent meningitis vaccines in the African meningitis belt.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Vaccinology

Background:

  • Bacterial meningitis remains a significant public health concern in the African meningitis belt.
  • Ethiopia faces a substantial burden of meningitis, necessitating identification of causative agents.

Purpose of the Study:

  • To identify the predominant bacterial pathogens responsible for meningitis in Ethiopian patients.
  • To determine the serogroups of Neisseria meningitidis causing infections.
  • To inform vaccine development and public health strategies.

Main Methods:

  • Retrospective analysis of bacterial meningitis cases in Ethiopia from 2012-2013.
  • Laboratory identification of causative organisms including Neisseria meningitidis and Streptococcus pneumoniae.
  • Serogrouping of detected Neisseria meningitidis isolates.

Main Results:

  • Out of 139 patients, Neisseria meningitidis (meningococci) was identified in 19.4% and Streptococcus pneumoniae (pneumococci) in 12.9%.
  • Detected meningococcal serogroups included A (n=11), W (n=7), C (n=1), and X (n=1).
  • Serogroup A was the most prevalent meningococcal serogroup identified.

Conclusions:

  • Meningococci and pneumococci are key bacterial pathogens causing meningitis in this Ethiopian cohort.
  • The identified serogroup distribution underscores the need for broad-spectrum meningitis vaccines.
  • Development of affordable, multivalent vaccines is critical for controlling meningitis in the African meningitis belt.